Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Merck
Express Scripts
Mallinckrodt
Medtronic

Last Updated: December 7, 2022

Trifluoperazine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for trifluoperazine hydrochloride and what is the scope of freedom to operate?

Trifluoperazine hydrochloride is the generic ingredient in two branded drugs marketed by Glaxosmithkline, Fosun Pharma, Wockhardt, Athem, Duramed Pharms Barr, Ivax Pharms, Mylan, Sandoz, and Watson Labs, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for trifluoperazine hydrochloride. Four suppliers are listed for this compound.

Summary for trifluoperazine hydrochloride
Recent Clinical Trials for trifluoperazine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Adrianna VlachosPhase 1/Phase 2
Lindner Center of HOPEPhase 2
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all trifluoperazine hydrochloride clinical trials

Pharmacology for trifluoperazine hydrochloride
Drug ClassPhenothiazine
Medical Subject Heading (MeSH) Categories for trifluoperazine hydrochloride

US Patents and Regulatory Information for trifluoperazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 085789-001 Approved Prior to Jan 1, 1982 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ivax Pharms TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 087614-001 Nov 19, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Athem TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040153-004 Oct 25, 1996 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Athem TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040153-001 Oct 25, 1996 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
McKinsey
Dow
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.